BHCM
FDMT icon

Brevan Howard Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Brevan Howard Capital Management’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,400
Closed -$143K – 1956
2025
Q3 		$143K Buy
+16,400
New +$98K ﹤0.01% 1821
2025
Q2 		– Sell
-14,800
Closed -$47.8K – 1895
2025
Q1 		$47.8K Buy
+14,800
New +$69.7K ﹤0.01% 1090
2024
Q3 		– Sell
-11,079
Closed -$233K – 1242
2024
Q2 		$233K Buy
+11,079
New +$278K 0.02% 852

Other funds holding FDMT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return